Alterome Therapeutics: Funding, Investors & Team (Sep 2026)
Alterome Therapeutics is a biotech company focused on precision oncology, creating targeted therapies to treat validated oncogenic mutations.
Alterome Therapeutics has raised $132M across 1 funding round on record, the most recent a Series B of $132M announced in Apr 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alterome Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Alterome Therapeutics Funding Rounds
Alterome Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Alterome Therapeutics Funding Compared to Other Biotechnology Startups
Alterome Therapeutics' latest round of $132M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alterome Therapeutics in Biotechnology and San Diego
Companies Similar to Alterome Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Alterome Therapeutics Funding FAQs
What does Alterome Therapeutics do?
Alterome Therapeutics is a biotech company focused on precision oncology, creating targeted therapies to treat validated oncogenic mutations.
How much funding has Alterome Therapeutics raised?
Alterome Therapeutics has raised $132M across 1 round on record. The most recent is a Series B of $132M announced in Apr 2024.
When did Alterome Therapeutics last raise funding?
Alterome Therapeutics' most recent funding round on record is a Series B of $132M, announced in Apr 2024.
Who founded Alterome Therapeutics?
FundedIQ lists Eric A Murphy (Founder) at Alterome Therapeutics.
Where is Alterome Therapeutics headquartered?
Alterome Therapeutics is based in San Diego, California, United States.
How many employees does Alterome Therapeutics have?
Alterome Therapeutics is in the 11-50 employee band.
How does Alterome Therapeutics' funding compare to other Biotechnology startups?
Alterome Therapeutics' latest round of $132M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Alterome Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alterome Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.